임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

12건 표시

3상모집 중· Metastatic Castration-resistant Prostate Cancer
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
리드: 바이오엔테크
상세 →NCT07365995
3상모집 중· Non-small Cell Lung Cancer (NSCLC)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
리드: BMS · 협력: 바이오엔테크
상세 →NCT07361497
3상모집 중· Non-Small Cell Lung Cancer (NSCLC)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
리드: BMS · 협력: 바이오엔테크
상세 →NCT07361510
3상모집 중단 (진행 중)· COVID-19
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
리드: 바이오엔테크 · 협력: 화이자
상세 →NCT07300839
3상모집 중· Breast Neoplasms
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
리드: 바이오엔테크 · 협력: BMS
상세 →NCT07173751
3상모집 중단 (진행 중)· COVID-19
A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19
리드: 바이오엔테크 · 협력: 화이자
상세 →NCT07222384
3상모집 중· Endometrial Cancer
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
리드: 바이오엔테크
상세 →NCT06340568
3상모집 중· Extensive-stage Small-cell Lung Cancer
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
리드: 바이오엔테크 · 협력: BMS
상세 →NCT06712355
3상모집 중단 (진행 중)· HER2-positive Breast Cancer
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
협력: 바이오엔테크
상세 →NCT06265428
3상모집 중단 (진행 중)· Metastatic Breast Cancer
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
협력: 바이오엔테크
상세 →NCT06018337
3상모집 중· Non Small Cell Lung Cancer
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
협력: 바이오엔테크
상세 →NCT05671510
3상모집 중단 (진행 중)· SARS-CoV-2 Virus
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
리드: 바이오엔테크 · 협력: 화이자
상세 →NCT05543616

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.